![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
With Africa emerging as the new breeding ground for innovative digital health solutions, an expert panel of global development and digital health leaders, including Vincent Keunen, Founder and CEO of Belgian American ehealth company Andaman7, will deliver a webinar roundtable to look at the digital healthcare challenges and opportunities in Africa. Hosted by African Sustainable Development Advisors Inc. (Afrisda, Inc.), “Beyond COVID-19: The Future of Digital Health in Africa”, will take place on Tuesday, June 29, at 1pm ET. [7pm CET; 6pm BST (5pm GMT)]. As a surviving cancer patient, digital health influencer and founder of a disruptive technology start-up, Vincent Keunen will present the patient perspective in digital health.
The COVID-19 pandemic has highlighted the need for global health solutions to benefit all nations. With Africa’s vast population mass bearing the world’s greatest disease incidence and significant healthcare shortages, the challenge and opportunity to increase the use of digital health solutions to benefit local populations, as well as increase real world evidence and data related to diverse populations for global therapy developments, makes this a key discussion.
Digital technologies have already formed a vital part of the COVID-19 response worldwide, offering case identification, contact tracing and evaluation. These rapid responses leverage billions of mobile phones, online datasets, low-cost computing resources and advances in machine learning and natural language processing. However, more needs to be done, not only to address existing challenges but to maintain momentum beyond the pandemic.
Dr Djo Matangwa, Co-founder and CEO of Afrisda Inc., explains:
“In addition to raising awareness around the future of digital health in Africa to encourage donors and investors to support African governments and organizations, as well as private sectors working in Africa, this webinar also seeks to support African health authorities to design laws and policies that will strengthen Africa’s health system as a key element in innovation and technology adoption. This event also marks an important collaboration between Andaman7 and Afrisda, Inc. who have signed a partnership agreement to support digital health implementation in Africa.
Discussing his presentation entitled: Can Africa Leapfrog Other Nations by Focussing on Patients in Digital Healthcare’, Keunen explains:
“COVID-19 has highlighted potential digital health roadblocks but this pressure on digitalization should be seen as an opportunity – not just for governments, but for innovators, donors and local organizations to provide essential health services that are affordable, reliable and tailored to local needs. There is already precedent for this. In telecommunications, many African countries skipped the classic landline step and went straight from no communications to mobile communications. The same was seen in the banking industry.
“In places where there is limited electricity and internet, innovations such as Andaman7 can make a huge difference because the solutions work offline. Someone could travel to a big city to charge their phone and connect to the internet and then use the app offline for a week. Looking beyond the patient, there is a huge opportunity to harness the power of decentralized trials, involving previously under-served demographics to improve research and treatments for all.”
As all United Nations member states have agreed to try to achieve universal health coverage by 2030, African leaders have been taking bold steps to improve healthcare systems and acknowledge the potential of digital health. Beyond COVID-19: The Future of Digital Health in Africa is part of Afrisda, Inc.’s workstream based on Collaboration, Partnership, Knowledge transfer and Partners’ Ownership.
Webinar details:
Beyond COVID-19: The Future of Digital Health in Africa brings together a panel of experts to discuss relevant and sustainable solutions to strengthen the health system in this digital health era.
- When: 1pm ET, Tuesday, June 29, 2021
- Where: Zoom Webinar.
- Panel:
- Djo Matangwa, Co-founder and CEO Afrisda Inc. Toronto, Canada
- Guest Speaker, Her Excellency Kilumba Nkulu, Vice-Minister of Public Health, DRC
- Vincent Keunen, Founder and CEO Andaman7, Liege, Belgium
- Daniel Messer, Vice President and Chief Information Officer for Digital Health & Technical Integration Population Services International, Washington DC, USA
- Rosine G. Assamoi, Co-founder and Executive Vice President Afrisda Inc. Toronto, Canada
- Eric Mutonj, Consultant ANICiis, Ministry of Health DRC
- Amer Sattar, Director and Consultant in Public Health, Guinea Conakry
- Mamello Muhanuuzi, Group Head of Medical Services & Quality Assurance, International Medical Group, Uganda
- Jan Kennis, Digital for Development Lead Expert, Enabel, Antwerp, Belgium
About Afrisda, Inc.
Afrisda, Inc. is an advisory group of international development experts and consultants from various horizons with a good knowledge and experience of the African landscape. Its goal is to help enhance and improve capacity building and systems strengthening initiatives of African governmental, national and local organizations in the implementation and delivery of quality sustainable development programs through innovative approaches. Afrisda, Inc., sees itself as a bridge between donors, foundations, the private sector, and national and local grassroots organizations in Africa.
About Vincent Keunen
Vincent Keunen is the founder and CEO of Andaman7. Previously, he developed numerous medical IT systems (a secure data exchange platform used by more than 90% of Belgian hospitals and family doctors, and a prevention EHR, managing today close to 1 million patients). Vincent was also the CIO of success story Lampiris and was awarded the CIO of the year prize for his work there. When Vincent was diagnosed with leukemia in 2007, and his 10-year-old son was diagnosed with bone cancer 3 months later, he decided to use his software engineering skills to provide all patients with a tool to manage their health information on their smartphone. That platform can now be used to improve medical research by collecting RWE (Real World Evidence) and PRO (Patient Reported Outcomes) while facilitating telemedicine, remote patient monitoring, and continuity of care.
About Andaman7
Andaman7 is a Belgian-American eHealth company and was created to significantly improve communication and efficiency in collaboration between healthcare actors: patients, doctors, and researchers. The company’s particular strengths are in RWE, QoL, PRO studies. Andaman7 ‘s patient centric health intermediation platform is designed to:
1 – help patients better manage their health data
2 -enable outcome measurement for pharma and research
3 – support disease management for hospitals and doctors.
Andaman7’s unique “security by design and privacy by default” architecture does not store medical data in the cloud. Data is only stored on the edge of the network (on mobile devices) and exchanged in a distributed peer to peer method. Andaman7 is compliant with GDPR and HIPAA and is also validated FDA 21 CFR part 11 and EU Annex 11 for clinical trials. Andaman7 is in use by citizens of over 30 countries and available in 20 languages.
